Clinical Trials Directory

Trials / Completed

CompletedNCT03908541

Peripheral Inflammation and Brain Structural Alterations in Patients With Disorders of Consciousness.

Status
Completed
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
First Affiliated Hospital of Zhejiang University · Academic / Other
Sex
All
Age
14 Years – 65 Years
Healthy volunteers
Accepted

Summary

Evidence suggests that inflammatory processes are key elements in the secondary effects of severe traumatic brain injury (TBI). The present study was designed to examine whether the peripheral inflammatory markers and brain structural alterations be associated with clinical measures and primary outcome following severe TBI. We hypothesized that peripheral inflammatory markers might be correlated with voxel-based GM volumes in patients with disorder of consciousness.

Detailed description

Background: Systemic inflammation, neurocognitive impairments, and morphologic brain changes are associated with outcome in patients with disorder of consciousness. Objective: The aim of this study is to assess the value of peripheral inflammatory markers and brain structural alterations in the chronic phase after severe traumatic brain injury. Methods: Serum levels of Interleukin (IL)-1β, IL-4, IL-6, IL-10, IL-13 and TNF-α were investigated in patients with chronic disorder of consciousness and healthy volunteers. Correlations were carried out between GM, WM, and CSF volumes and inflammatory cytokines levels. In addition, the Coma Recovery Scale-Revised (CRS-R) score was used to quantify the severity, and long-term recovery clinical outcome at 12 month was determined according to Glasgow Outcome Scale (GOS).

Conditions

Timeline

Start date
2015-01-01
Primary completion
2022-12-01
Completion
2022-12-31
First posted
2019-04-09
Last updated
2024-05-07

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03908541. Inclusion in this directory is not an endorsement.